Home/Edulis Therapeutics/Dr. Christopher Bettinger
DC

Dr. Christopher Bettinger

Scientific Advisor

Edulis Therapeutics

Edulis Therapeutics Pipeline

DrugIndicationPhase
EDLS-201Inflammatory Bowel Disease (Crohn's Disease)Preclinical
EDLS-302Microbiome ModulationDiscovery
EDLS-401Weight LossDiscovery
Endoscopic Accessory PlatformPlatform Product (Device)Prototyping